<

 
Data updated 2025-04-30 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date09747531.3 (espacenet)  (Federated)  (European Patent Register), 20090514
Patent/reg. no. and dateDK/EP 2297100, 20121031
Publication date20110323
Priority no. and dateUS 53722, 20080516
EP pub. no. and date EP 2297100 20110323
Effective date
Applicant/ownerEli Lilly & Company, Lilly Corporate Center
Indianapolis, IN 46285, US
Applicant ref. no.P81205500DK00E
InventorJADHAV, Prabhakar, Kondaji, Eli Lilly and Company
Lilly Corporate Center
Indianapolis, IN 46285, US,
KRISHNAN, Venkatesh, Eli Lilly And Company
Lilly Corporate Center
Indianapolis, IN 46285, US,
KIM, Euibong, Jemes, Eli Lilly And Company
Lilly Corporate Center
Indianapolis, IN 46285, US
RepresentativeZacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S
Opponent
IPC ClassA61K 31/403 (2006.01) , A61K 31/4439 (2006.01) , A61P 19/10 (2006.01) , A61P 21/00 (2006.01) , A61P 5/26 (2006.01) , C07D 209/94 (2006.01) , C07D 401/06 (2006.01) , C07D 403/06 (2006.01) 
TitleTETRAHYDROCYCLOPENTA[B]INDOL-ANDROGENRECEPTOR-MODULATORER
Int. application no.US2009043875
Int. publication no.WO2009140448
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact